Eosinophilic esophagitis: From pathophysiology to diagnosis, monitoring and treatment
Luisa Bertin, Emma Sirinic, Matteo Ghisa, Tarek Arraf et autres
3 citationsEuropean Journal of Clinical Investigation
E V Savarino
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
12Publications signalées
3Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Inflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsAutoimmune and Inflammatory DisordersMicroscopic ColitisPsoriasis: Treatment and Pathogenesis
Publications récentes
DOP041 Pregnancy and Infant Outcomes After In Utero Exposure to JAK Inhibitors in Inflammatory Bowel Disease: A Global Multicenter Cohort Study
M Julsgaard, S M Baunwall, C Seow, D Duricova et autres
0 citationsJournal of Crohn s and Colitis
P1012 Real-world comparative effectiveness of risankizumab versus other biologics in perianal Crohn’s disease: a multicentre retrospective cohort study
Amer Dakka, L Van Lierop, Frank Hoentjen, Paige T M Shelemey et autres
0 citationsJournal of Crohn s and Colitis
P0598 MIRACLE-UC: Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in Patients with Ulcerative Colitis - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).
B Barberio, A Todeschini, Lucrezia Laterza, Anna Viola et autres
0 citationsJournal of Crohn s and Colitis
P0199 Longitudinal trajectories of disability in patients with Inflammatory Bowel Disease: a multicenter prospective study
O M Nardone, G Calabrese, F Caprioli, M C Fantini et autres
0 citationsJournal of Crohn s and Colitis
P0664 Risk of relapse and retreatment success after vedolizumab discontinuation in patients with IBD in long-standing remission: a retrospective study from the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
G Dragoni, Tommaso Innocenti, S Festa, C Felice et autres
0 citationsJournal of Crohn s and Colitis
DOP035 Upadacitinib: Personalized Goals for Remission and Disease Evaluation in Patients with Crohn’s Disease (UPGRADE-CD) - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).
B Barberio, F Scaldaferri, C Bezzio, G Dragoni et autres
0 citationsJournal of Crohn s and Colitis
P0780 Effect of JAK inhibitors on extra-intestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease
M Truyens, X Tolstoy, Giuseppe Calabrese, Paola Balestrieri et autres
0 citationsJournal of Crohn s and Colitis
P0814 Effect of IL-23 inhibitors on extra-intestinal manifestations and concurrent immune-mediated inflammatory diseases in patients with inflammatory bowel disease
M Truyens, X Tolstoy, G Calabrese, Paola Balestrieri et autres
0 citationsJournal of Crohn s and Colitis
P0316 Natural History of Newly Diagnosed Mild Crohn’s Disease: Risk of Progression and Predictors in an Italian Multicentre Cohort
Marco Mendolaro, Anna Viola, G Dragoni, D Pugliese et autres
0 citationsJournal of Crohn s and Colitis
P0961 An inverse propensity score-weighted comparison between Vedolizumab, Ustekinumab, and Tofacitinib in ulcerative colitis patients refractory or intolerant to anti-TNF therapies
G Mocci, E V Savarino, Luisa Bertin, W Elisei et autres
0 citationsJournal of Crohn s and Colitis
P1300 Transition of Pediatric-Onset Inflammatory Bowel Disease to Adult Care: A Multicenter Italian Cohort Study
G Orrù, M F Onidi, L Ceccarelli, C Felice et autres
0 citationsJournal of Crohn s and Colitis
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.